🏆 Deal of the Week · CW 27/2022
YuLife raised USD 120 million in a Series C round in July 2022, at a valuation of USD 800 million. The round was backed by a broad syndicate of ten investors including Anthemis Exponential Ventures, Creandum, and Dai-ichi Life, among others. This round was recognised as Venionaire DealMatrix's Deal of the Week for KW 27/2022.
YuLife — key deal facts
| Company | YuLife |
| Founded | 2016 |
| Headquarters | London, United Kingdom |
| Amount raised | USD 120M |
| Valuation | USD 800M |
| Round | Series C |
| Investors | Anthemis Exponential Ventures (https://www.anthemis.com/) Creandum (https://www.creandum.com/) Dai-ichi Life (https://www.dai-ichi-life.co.jp/english/) Eurazeo (https://www.eurazeo.com/en) Latitude (https://www.latitudeim.com/) LocalGlobe (https://localglobe.vc/) MMC Ventures (https://mmc.vc/) Notion Capital (https://www.notion.vc/) OurCrowd (https://www.ourcrowd.com/) Target Global (https://www.targetglobal.vc/) |
| Sectors | Employee Benefits |
Who invested in YuLife?
The Series C attracted a geographically diverse investor group spanning venture capital, institutional insurance, and growth equity: Anthemis Exponential Ventures, Creandum, Dai-ichi Life, Eurazeo, Latitude, LocalGlobe, MMC Ventures, Notion Capital, OurCrowd, and Target Global. The participation of Dai-ichi Life, a major Japanese insurer, alongside specialist insurtech and fintech investors such as Anthemis and MMC Ventures, reflects both strategic and financial conviction in YuLife's model. The breadth of the syndicate underscores cross-border appetite for embedded employee benefits platforms at scale.
What does YuLife do?
YuLife is a London-headquartered employee benefits platform founded in 2016 by CEO Sammy Rubin, who previously led Vitality. The company combines group life insurance with health and wellbeing tools in a single product suite, covering staff wellbeing challenges, virtual GP services, and on-demand mental health support. Its flagship offering is a gamified app that rewards employees with YuCoins for engaging in healthy activities, creating a behavioural incentive layer on top of traditional group life insurance. YuLife targets the corporate employee benefits market, positioning wellness engagement as a driver of improved insurance outcomes.
YuLife valuation & multiples
No existing multiples analysis was provided for this deal. For context on valuation benchmarks applicable to employee benefits and insurtech platforms, readers can explore the relevant sector multiples pages on DealMatrix, where EV/Sales and EV/EBITDA ranges for comparable companies are maintained and updated regularly.
Explore the benchmarks: Series C.
Frequently asked questions
How much did YuLife raise in its Series C?
YuLife raised USD 120 million in its Series C round in July 2022.
What is YuLife's valuation?
YuLife was valued at USD 800 million at the time of its Series C round.
Who invested in YuLife?
The Series C investors include Anthemis Exponential Ventures, Creandum, Dai-ichi Life, Eurazeo, Latitude, LocalGlobe, MMC Ventures, Notion Capital, OurCrowd, and Target Global.
When was YuLife founded and where is it based?
YuLife was founded in 2016 and is headquartered in London, United Kingdom.
Source: original announcement — read the full report.